一种穿透细胞的双特异性抗体抑制了B型肝炎病毒的复制和分泌
Chongwei Xie1, Bing Zhou2, Da Yao3
1Medical Research Center, Yuebei People's Hospital, Shantou University Medical College, 512025, Shaoguan, China; Shenzhen Immuthy Biotech Co., Ltd, 518107, Shenzhen, Guangdong, China.
Virus research
|January 25, 2025
概括
一种新的两种特异性抗体,Anti-preS1 × Anti-HBcAg-R9TAT,有效地向乙型肝炎病毒 (HBV) 组件. 这种治疗候选药物抑制HBV复制和分泌,为治疗慢性HBV感染提供了一个有前途的新方法.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药物发现 药物发现 药物发现
背景情况:
- 乙型肝炎病毒 (HBV) 是慢性肝病和肝细胞癌 (HCC) 的重要原因.
- 目前针对HBV的抗病毒疗法不足以根除病毒或防止HCC的发展.
- 乙型肝炎病毒核囊,包括乙型肝炎核心抗原 (HBcAg) 和病毒DNA,对于病毒复制至关重要.
研究的目的:
- 开发一种新的治疗策略,针对病毒抑制的关键HBV组件.
- 评估细胞透双特异抗体在抑制HBV复制和分泌方面的疗效.
主要方法:
- 开发一种细胞透的双特异抗体,Anti-preS1 × Anti-HBcAg-R9TAT,针对HBcAg和preS1.
- 抗体与R9TAT细胞透的融合,以增强细胞吸收.
- 在体外评估抗体识别病毒抗原和抑制HBV标记物的能力.
主要成果:
- 抗-preS1 × 抗-HBcAg-R9TAT抗体有效地识别了preS1和HBcAg抗原.
- 抗体显示出有效的内部化进入活细胞.
- 在实验室中观察到细胞外乙肝表面抗原 (HBsAg) 和乙肝包膜抗原以及细胞内HBsAg和HBcAg的显著抑制.
结论:
- 穿透细胞的双特异性抗体代表了B型肝炎病毒的新型治疗方法.
- 这种抗体候选物在抑制HBV复制和分泌方面表现有前途.
- 这种抗体的进一步开发可能会导致慢性HBV感染和HCC预防的新疗法.
更多相关视频
相关概念视频
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...


